Electroacupuncture treatment of peripheral neuropathy after taxane chemotherapy for breast cancer
Breast cancer patients diagnosed by pathology;
EOOG score is 0 or 1;
The age range for enrollment is between 18 and 75 years old; ④ Accept chemotherapy regimens based on taxane drugs (alone or in combination);
Accept regular follow-up visits; ⑨ There is complete pathological data available.
Non breast cancer patients;
Received electroacupuncture treatment within 6 months prior to the start of the study;
Patients who experience intolerable toxic side effects during standard dose chemotherapy and terminate the chemotherapy cycle;
Prior to enrollment, there was a history of peripheral neuropathy;